| Effectiveness of a Typhoid Conjugate Vaccine in DRC (NCT05119426) | International Vaccine Institute | 2022-02-11 |
| Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (NCT04852185) | International Vaccine Institute | 2021-08-24 |
| TyVECO: Surveillance Protocol (NCT05562102) | International Vaccine Institute | 2021-08-09 |
| Mobile Point of Care Diagnostic Testing for Ebola Virus Disease in DRC (NCT04235361) | University of Stirling | 2021-01-15 |
| Commercial Typhoid Tests Validation (NCT04673487) | Kenya Medical Research Institute | 2021-01-01 |
| Commercial Typhoid Tests Validation Trial (NCT04801602) | Foundation for Innovative New Diagnostics, Switzerland | 2020-10-25 |
| Non-inferiority and Safety Study of EuTCV Compared to Typbar-TCV in Healthy 6 Months-45 Years Aged Participants (NCT04830371) | EuBiologics Co.,Ltd | 2020-09-07 |
| Induction of Gut Permeability by an Oral Vaccine (NCT04083950) | USDA, Western Human Nutrition Research Center | 2019-12-04 |
| Comparison of Two Drugs Regimen in Treatment of Complicated Typhoid Fever in Children (NCT04154722) | Ziauddin University | 2019-06-20 |
| Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults (NCT03956524) | EuBiologics Co.,Ltd | 2019-03-16 |
| Typhoid Conjugate Vaccine Introduction in Navi Mumbai, India (NCT03554213) | Stanford University | 2018-07-02 |
| Safety and Immunogenicity of Typhax, a Typhoid Vaccine (NCT03926455) | Matrivax Research and Development Corporation | 2016-03-28 |
| Vaccines Against Salmonella Typhi (NCT02324751) | University of Oxford | 2015-09-01 |
| Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers (NCT02391909) | Bavarian Nordic | 2015-08-26 |
| Investigating Enteric Fever - Salmonella Typhi and Paratyphi Challenge Study (NCT02192008) | University of Oxford | 2014-12-01 |
| Typhoid Fever: Combined vs. Single Antibiotic Therapy (NCT02224040) | Sheba Medical Center | 2013-08-01 |
| Global Genomic and Proteomic Profiling of African Children With Typhoid Fever (NCT02947295) | University of Nebraska | 2012-09-13 |
| Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects (NCT01608815) | Sanofi Pasteur, a Sanofi Company | 2012-05-01 |
| Understanding Typhoid Disease After Vaccination (NCT01405521) | University of Oxford | 2011-10-07 |
| Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults (NCT01438996) | Novartis | 2011-10-01 |
| Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants (NCT01437267) | Novartis | 2011-10-01 |
| Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever (NCT01421693) | Oxford University Clinical Research Unit, Vietnam | 2011-09-01 |
| Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adults, Children, Older Infants and Infants (NCT01229176) | Novartis | 2011-03-01 |
| Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old) (NCT01193907) | Novartis | 2010-10-01 |
| Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old) (NCT01123941) | Novartis | 2010-05-01 |
| Long Term Protection by and Persistence of Vi Antibodies Induced by Vi-rEPA Conjugate Vaccines in Vietnamese Children Injected at 2-5 Years or at 5-8 Years of Age (NCT00386789) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-10-05 |
| Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants (NCT00342628) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-07-01 |
| CVD 909 Vi Prime Boost Study (NCT00326443) | National Institute of Allergy and Infectious Diseases (NIAID) | 2006-02-01 |
| Salmonella Typhi Vi O-Acetyl Pectin-rEPA Conjugate Vaccine (NCT00277147) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2006-01-09 |